Evidence map›Paper›PMID 38002062›Full record

ArticleBiomedicines2023

Intracellular Major Histocompatibility Complex Class II and C-X-C Motif Chemokine Ligand 10-Expressing Neutrophils Indicate the State of Anti-Tumor Activity Induced by

Yuji Takeda, Tomoyuki Kato, Saima Sabrina, Sei Naito, Hiromi Ito, Naoto Emi, Yuya Kuboki, Yuki Takai, Hiroki Fukuhara, Masaki Ushijima and 13 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 2 institutions in 1 country.

Yuji TakedaDepartment of Immunology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.ORCID 0000-0002-0823-1802
Tomoyuki KatoDepartment of Urology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.
Saima SabrinaDepartment of Immunology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.ORCID 0000-0001-7203-2886
Sei NaitoDepartment of Urology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.ORCID 0000-0002-6104-4344
Hiromi ItoDepartment of Urology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.
Naoto EmiDepartment of Immunology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.
Yuya KubokiDepartment of Urology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.
Yuki TakaiDepartment of Urology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.
Hiroki FukuharaDepartment of Urology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.
Masaki UshijimaDepartment of Urology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.
Takafumi NarisawaDepartment of Urology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.
Mayu YagiDepartment of Urology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.
Hidenori KannoDepartment of Urology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.ORCID 0000-0001-9185-2134
Toshihiko SakuraiDepartment of Urology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.
Hayato NishidaDepartment of Urology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.
Akemi ArakiDepartment of Immunology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.
Yoshitaka ShimotaiDepartment of Infectious Diseases, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.ORCID 0000-0002-9612-3261
Mikako NagashimaDepartment of Immunology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.
Yusuke NouchiDepartment of Immunology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.
Shinichi SaitohDepartment of Immunology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.ORCID 0000-0001-7523-8177
Hidetoshi NaraDepartment of Biological Sciences, Faculty of Science and Engineering, Ishinomaki Senshu University, Miyagi 986-8580, Japan.
Norihiko TsuchiyaDepartment of Urology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.ORCID 0000-0003-4242-2618
Hironobu AsaoDepartment of Immunology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.ORCID 0000-0002-1051-4799
Yamagata University · JPIshinomaki Senshu University · JP

Funding

Grant-in-Aid for Scientific Research (KAKENHI) (C) 17K11122, 20K09554 and 23K08751
6 · The paper itself

Abstract

(1) Background: Inflammatory responses induce the formation of both anti-tumor and pro-tumor neutrophils known as myeloid-derived suppressor cells (MDSCs). Intermittent intravesical infusion of

Indexed as

Bacillus Calmette–Guérin (BCG)bladder cancerC-X-C motif chemokine ligand 10 (CXCL10)major histocompatibility complex (MHC) class IImyeloid-derived suppressor cells (MDSCs)neutrophils

Identifiers

PMID38002062
PMCPMC10669614
OpenAlexW4388694899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.